top of page


These are the clinical trials currently available in the UK in respect of ALK-positive lung cancer.

UK Trials that are no longer recruiting new patients


A study looking at further treatment after initial treatment for advanced non small cell lung cancer. 


A trial of stereotactic body radiotherapy with targeted drug treatment in advanced non small lung cancer 

World-Wide Studies and Trials

ALK+ Trials/Studies

ALK Positive (USA) Research Library

Studies of Interest

Local Therapy for


Funding approved for a vaccine study in the UK

Alectinib after surgery at Stages I-III

FDA approved

April 2024


Lorlatinib as 1st line treatment

A summary of vaccine studies in the UK

ALK Life Study

A longitudinal study being carried out by ALK Positive Inc (USA)

Anyone with lungs can get lung cancer.

bottom of page